RG
AMED

Redmile Group’s Amedisys AMED Stock Holding History

Redmile Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150,376
Closed -$22.4M – 72
2021
Q3 		$22.4M Buy
150,376
+17,918
+14% +$3.72M 0.39% 52
2021
Q2 		$32.4M Sell
132,458
-522
-0.4% -$137K 0.48% 53
2021
Q1 		$35.2M Sell
132,980
-500
-0.4% -$141K 0.5% 54
2020
Q4 		$39.2M Sell
133,480
-6,700
-5% -$1.72M 0.47% 51
2020
Q3 		$33.1M Sell
140,180
-85,985
-38% -$19.5M 0.61% 45
2020
Q2 		$44.9M Buy
226,165
+48,600
+27% +$9.06M 0.83% 36
2020
Q1 		$32.6M Sell
177,565
-3,500
-2% -$623K 0.91% 36
2019
Q4 		$30.2M Buy
181,065
+178,745
+7,705% +$26.6M 0.72% 36
2019
Q3 		$304K Hold
2,320
– – 0.01% 64
2019
Q2 		$282K Buy
+2,320
New +$275K 0.01% 72
2018
Q4 		– Sell
-2,725
Closed -$341K – 80
2018
Q3 		$341K Hold
2,725
– – 0.01% 75
2018
Q2 		$233K Buy
+2,725
New +$200K 0.01% 76
2017
Q4 		– Sell
-283,648
Closed -$15.9M – 71
2017
Q3 		$15.9M Buy
283,648
+280,292
+8,352% +$14.8M 0.78% 38
2017
Q2 		$211K Sell
3,356
-1,470
-30% -$85.6K 0.01% 61
2017
Q1 		$247K Buy
+4,826
New +$230K 0.02% 58

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Redmile Group's AMED Position: Q4 2021 in Review

Redmile Group sold out of Amedisys (AMED) in Q4 2021, closing a stake of 150,376 shares — an estimated $22.4M sold.

Redmile Group first reported a position in AMED in Q1 2017 and held it in 15 quarters. The position peaked at $44.9M in Q2 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Redmile Group reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Redmile Group sold 150,376 Amedisys shares in Q4 2021, an estimated $22.4M.
  • Redmile Group first reported a position in Amedisys in Q1 2017 and held it in 15 quarters.
  • Redmile Group's Amedisys position peaked at $44.9M in Q2 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Redmile Group's 13F filing for Q4 2021, filed 14 Feb 2022.